Remission and recovery in lurasidone-treated patients with bipolar depression: post-hoc analysis of a 6-week, placebo-controlled trial followed by a 6-month extension

被引：0
|
作者：
Loebel, A. [1 ]
Siu, C. [2 ]
Rajagopalan, K. [3 ]
Pikalov, A. [4 ]
Cucchiaro, J. [5 ]
Ketter, T. [6 ]
机构：
[1] Sunovion Pharmaceut Inc, Ft Lee, NJ USA
[2] COS Consulting, Data Sci & Analyt, Montreal, PQ, Canada
[3] Sunovion Pharmaceut Inc, Hlth Econ & Outcomes Res, Marlborough, MA USA
[4] Sunovion Pharmaceut Inc, Clin Dev & Med Affairs, Ft Lee, NJ USA
[5] Sunovion Pharmaceut Inc, Clin Operat, Ft Lee, NJ USA
[6] Stanford Univ, Psychiat & Behav Sci, Stanford, CA 94305 USA
来源：
BIPOLAR DISORDERS | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] Remission in Lurasidone-treated Patients with Bipolar I Depression: Post-hoc Analysis of a 6-week, Placebo-controlled Trial Followed by a 6-month Extension
    Loebel, A.
    Siu, C.
    Pikalov, A.
    Rajagopalan, K.
    Cucchiaro, J.
    Ketter, T.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [2] Symptomatic and Functional Remission and Recovery in Lurasidone-treated Patients with Bipolar Depression: Post-hoc Analysis of a 6-week, Placebo-Controlled Trial Followed by a 6-Month Extension
    Loebel, Antony
    Siu, Cynthia
    Rajagopalan, Krithika
    Pikalov, Andrei
    Cucchiaro, Josephine
    Ketter, Terence
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S390 - S390
  • [3] Recovery in bipolar depression: analysis of a 6-week, placebo-controlled lurasidone trial followed by a 6-month continuation study
    Siu, C.
    Loebel, A.
    Rajagopalan, K.
    Pikalov, A.
    Cucchiaro, J.
    Ketter, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S492 - S492
  • [4] Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study
    Loebel, Antony
    Siu, Cynthia
    Rajagopalan, Krithika
    Pikalov, Andrei
    Cucchiaro, Josephine
    Ketter, Terence A.
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 376 - 382
  • [5] Lurasidone in the treatment of sleep disturbance associated with bipolar depression: post-hoc analysis of a placebo-controlled trial followed by a long-term extension study
    Tsai, J.
    Thase, M.
    Siu, C.
    Pikalov, A.
    Loebel, A.
    BIPOLAR DISORDERS, 2016, 18 : 121 - 122
  • [6] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Correll, Christoph
    Goldman, Robert
    Tocco, Michael
    Pikalov, Andrei
    Hsu, Jay
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S293 - S294
  • [7] Lurasidone for bipolar I depression with anxiety: Post-hoc analysis of a randomized, placebo-controlled study
    Hagi, Katsuhiko
    Shima, Hirokazu
    Inoue, Takeshi
    BIPOLAR DISORDERS, 2021, 23 : 70 - 71
  • [8] EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VS. PREVIOUSLY TREATED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Correll, C. U.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2021, 55 (1_SUPPL): : 103 - 103
  • [9] Galantamine in AD - A 6-month randomized, placebo-controlled trial with a 6-month extension
    Raskind, MA
    Peskind, ER
    Wessel, T
    Yuan, W
    NEUROLOGY, 2000, 54 (12) : 2261 - 2268
  • [10] Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Sarma, K.
    Kroger, H.
    Calabrese, J. R.
    Sachs, G.
    BIPOLAR DISORDERS, 2013, 15 : 138 - 138
12345